These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1827735)

  • 1. A phase II study with mitomycin and vindesine in metastatic pretreated breast cancer.
    Hupperets PS; Fickers MM; Schouten LJ; Blijham GH
    Eur J Cancer; 1991; 27(4):520-1. PubMed ID: 1827735
    [No Abstract]   [Full Text] [Related]  

  • 2. Long duration of response with vindesine-mitoxantrone-mitomycin (VMMc) combination chemotherapy in metastatic breast cancer: a pilot phase II study.
    Belpomme D; Heritier F; Gisselbrecht C; Marty M; Michaud G; Le Rol A; Cour V; George C; Maral J
    Cancer Treat Rep; 1987 Sep; 71(9):845-7. PubMed ID: 3621218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salvage chemotherapy with mitomycin C and vindesine in metastatic carcinoma of the breast].
    Ardizzoni A; Lionetto R; Repetto L; Pronzato P; Rosso R
    G Ital Chemioter; 1985; 32(1):61-2. PubMed ID: 3938418
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
    Rausa L; Russo A; Gebbia V; Gebbia N; D'Alessandro N; Palmeri S
    J Cancer Res Clin Oncol; 1991; 117(3):266-8. PubMed ID: 1709643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancer.
    Falkson CI; Falkson HC; Falkson G
    Am J Clin Oncol; 1988 Aug; 11(4):431-4. PubMed ID: 2970218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancer.
    Ardizzoni A; Pronzato P; Canobbio L; Lionetto R; Rosso R
    J Cancer Res Clin Oncol; 1985; 110(1):77-8. PubMed ID: 4019571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prolonged remissions induced by the combination vindesine, mitoxantrone, mitomycine C in metastatic breast cancers].
    Belpomme D; Cour V; Gisselbrecht C; Le Rol A; Mignot L; Marty M; Godeffroy W; Maral J
    Presse Med; 1987 Apr; 16(13):635. PubMed ID: 2952982
    [No Abstract]   [Full Text] [Related]  

  • 8. Vindesine and mitomycin C in metastatic breast cancer. A Southeastern Cancer Study Group Trial.
    Lyss AP; Luedke SL; Einhorn L; Luedke DW; Raney M
    Oncology; 1989; 46(6):357-9. PubMed ID: 2511534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vindesine and mitomycin C in chemotherapy: refractory advanced breast cancer.
    Di Costanzo F; Gori S; Tonato M; Buzzi F; Crino L; Grignani F; Davis S
    Cancer; 1986 Mar; 57(5):904-7. PubMed ID: 3002594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of non-small cell bronchial cancer with mitomycin C, vindesine and cisplatin. Results of a phase II study].
    Koschel G; Kaukel E; Hain E
    Onkologie; 1987 Apr; 10(2):90-5. PubMed ID: 3035447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium).
    Sculier JP; Klastersky J; Dumont JP; Vandermoten G; Rocmans P; Libert P; Ravez P; Becquart D; Mommen P; Dalesio O
    Cancer Treat Rep; 1986 Jun; 70(6):773-5. PubMed ID: 3731139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
    Bonomi PD; Pazdur R; Stolbach L; Mason B; Ettinger D
    Cancer Treat Rep; 1986 Dec; 70(12):1447-8. PubMed ID: 3024827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M; Kiura K; Okabe K; Toki H; Kimura M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Rosell R; Abad-Esteve A; Moreno I; Barnadas A; Carles J; Fernandez C; Ribelles N; Culubret M
    Cancer; 1990 Apr; 65(8):1692-9. PubMed ID: 2156597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
    Leyvraz S; Barrelet L; Savary M; Bernasconi S
    Cancer Treat Rep; 1987 Jan; 71(1):81-2. PubMed ID: 3791271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
    Einhorn LH; Loehrer PJ; Williams SD; Meyers S; Gabrys T; Nattan SR; Woodburn R; Drasga R; Songer J; Fisher W
    J Clin Oncol; 1986 Jul; 4(7):1037-43. PubMed ID: 3088219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).
    Riggi M; Ruffie P; Voisin S; Monnet I; de Cremoux H; Saltiel JC; Martin M; Vergne L; Huet J; Cvitkovic E
    Eur J Cancer; 1991; 27(10):1238-42. PubMed ID: 1659842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
    Hayashi Y; Kato M; Matsuura T; Yamada Y; Adachi S; Ito G; Yamamoto K; Takeuchi T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.